Catch us at an upcoming conference or tradeshow – or sign up for one of our own upcoming events and Benchtalk forums.
November 11, 2019Hamburg, Germany
We'll be partnering at the 25th annual BIO-EUROPE, Europe's largest partnering conference serving the global biotechnology industry. As Benchling expands internationally, we are looking forward to meeting the global leaders and innovators of the life science industry through one-on-one meetings and networking receptions.
We are presenting at the Proventa Bioinformatics Strategy Meeting, a conference that will focus on in-depth exploration of bioinformatics trends and topics. Through executive roundtable discussions, delegates with shared key challenges are grouped together to discuss topics like data management/analytics, next-generation sequencing, artificial intelligence and more. These intimate 60-minute sessions scheduled throughout the day allow everyone to raise relevant questions or contribute insightful experiences.
We are thrilled to be exhibiting and presenting at CMS. Cell-based Meat, Cultivated Meat, Craft Meat, no matter what you call it, the importance of cellular agriculture goes a long way for the global food system. It will take not only science and feasibility but marketing and a strong brand perception to allow us to break through and make change.
PEGS Europe | Protein & Antibody Engineering Summit 2019
November 18, 2019Lisbon, Portugal
Benchling will be in beautiful Lisbon exhibiting and partnering at PEGS Europe, the largest European conference covering all aspects of protein and antibody engineering. Programs will also focus on analytical, protein purification and expression, oncology ADC's and bi-specifics, and immunotherapy including CAR-T and TCR. We are looking forward to networking and meeting with industry biotech and biopharma leaders at the event!
Benchling will be exhibiting at the World Vaccine & Immunotherapy Congress. While the conference will continue to focus on the vaccine and immunotherapy industry, the event has expanded significantly to dive deeper into topics surrounding vaccine development, cancer immunotherapy, funding and partnerships, plus exploring new topics in clinical trials & development, bioprocessing, manufacturing and delivery, and antibody development for infectious disease and cancer.